Mitoquinone supplementation alleviates oxidative stress and pathologic outcomes following repetitive mild traumatic brain injury at a chronic time point.
- DOI
- 10.1016/j.expneurol.2022.113987
- Published
- 2022 May
- Container
- Experimental neurology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.expneurol.2022.113987,
title = {Mitoquinone supplementation alleviates oxidative stress and pathologic outcomes following repetitive mild traumatic brain injury at a chronic time point.},
author = {Tabet M and El-Kurdi M and Haidar MA and Nasrallah L and Reslan MA and Shear D and Pandya JD and El-Yazbi AF and Sabra M and Mondello S and Mechref Y and Shaito A and Wang KK and El-Khoury R and Kobeissy F},
year = {2022},
journal = {Experimental neurology},
doi = {10.1016/j.expneurol.2022.113987},
url = {https://doi.org/10.1016/j.expneurol.2022.113987}
}RIS
TY - JOUR TI - Mitoquinone supplementation alleviates oxidative stress and pathologic outcomes following repetitive mild traumatic brain injury at a chronic time point. AU - Tabet M AU - El-Kurdi M AU - Haidar MA AU - Nasrallah L AU - Reslan MA AU - Shear D AU - Pandya JD AU - El-Yazbi AF AU - Sabra M AU - Mondello S AU - Mechref Y AU - Shaito A AU - Wang KK AU - El-Khoury R AU - Kobeissy F PY - 2022 JO - Experimental neurology DO - 10.1016/j.expneurol.2022.113987 UR - https://doi.org/10.1016/j.expneurol.2022.113987 ER -
APA
M, T., M, E., MA, H., L, N., MA, R., D, S., JD, P., AF, E., M, S., S, M., Y, M., A, S., KK, W., R, E., & F, K. (2022). Mitoquinone supplementation alleviates oxidative stress and pathologic outcomes following repetitive mild traumatic brain injury at a chronic time point.. Experimental neurology. https://doi.org/10.1016/j.expneurol.2022.113987
Source records
- pubmed · retrieved 2026-09-26T19:59:41.344Z